Hu, Kai-Lun
Yang, Rui
Xu, Huiyu
Mol, Ben W.
Li, Rong https://orcid.org/0000-0003-0305-5579
Wang, Rui
Article History
Received: 21 March 2022
Accepted: 4 July 2022
First Online: 23 July 2022
Declarations
:
: Institutional Review Board (IRB) approval for this retrospective cohort study was obtained from the Ethics Committee of Peking University Third Hospital (reference: 2018S2-002).
: BWM is supported by a NHMRC Investigator grant (GNT1176437), and BWM reports consultancy for ObsEva, Merck Merck KGaA, iGenomix, and Guerbet. The other authors have no conflict of interest to declare.